You are not logged in (login)

Research Center

PHONEBOOK

Philippe Tessier

Formation
coming soon

No active offer

All active job offers
Principal area
Infectious and immune diseases
Address
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier, RC-709
Québec (Québec)
CANADA G1V 4G2

Phone
+1 418-525-4444, poste 47607
Fax
+1 418-654-2715
Email
philippe.tessier@crchudequebec.ulaval.ca

Research project(s) recognized by Université Laval (in French)

Other active research project(s)

No active project

Recent publications (see all publication from this researcher)

Laouedj M, Tardif MR, Gil L, Raquil MA, Lachaab A, Pelletier M, Tessier PA, Barabe F. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Blood,  2017. Epub
Rousseau LS, Pare G, Lachhab A, Naccache PH, Marceau F, Tessier P, Pelletier M, Fernandes M. S100A9 potentiates the activation of neutrophils by the etiological agent of gout, monosodium urate crystals. Journal of leukocyte biology,  2017. Epub
El Azreq MA, Kadiri M, Boisvert M, Page N, Tessier PA, Aoudjit F. Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway. Oncotarget,  2016. 7: 44975-44990
Yoon J, Leyva-Castillo JM, Wang G, Galand C, Oyoshi MK, Kumar L, Hoff S, He R, Chervonsky A, Oppenheim JJ, Kuchroo VK, van den Brink MR, Malefyt RW, Tessier PA, Fuhlbrigge R, Rosenstiel P, Terhorst C, Murphy G, Geha RS. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. The Journal of experimental medicine,  2016. 213: 2147-66
Tsai SY, Segovia JA, Chang TH, Shil NK, Pokharel SM, Kannan TR, Baseman JB, Defrene J, Page N, Cesaro A, Tessier PA, Bose S. Regulation of TLR3 Activation by S100A9. Journal of immunology (Baltimore, Md. : 1950) ,  2015. 195: 4426-37
El Azreq MA, Arseneault C, Boisvert M, Page N, Allaeys I, Poubelle PE, Tessier PA, Aoudjit F. Cooperation between IL-7 Receptor and Integrin alpha2beta1 (CD49b) Drives Th17-Mediated Bone Loss. Journal of immunology (Baltimore, Md. : 1950) ,  2015. 195: 4198-209
Tardif MR, Chapeton-Montes JA, Posvandzic A, Page N, Gilbert C, Tessier PA. Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux. Journal of immunology research,  2015. 2015: 296149
Cormier K, Harquail J, Ouellette RJ, Tessier PA, Guerrette R, Robichaud GA. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells. Anti-cancer agents in medicinal chemistry,  2014. 14: 35-45
Simard JC, Noel C, Tessier PA, Girard D. Human S100A9 potentiates IL-8 production in response to GM-CSF or fMLP via activation of a different set of transcription factors in neutrophils. FEBS letters,  2014. 588: 2141-6
Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, Tessier PA, Tardif MR, Cesaro A, Bose S. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS pathogens,  2014. 10: e1003848
© 2017 All rights reserved CRCHU de Québec